Details for New Drug Application (NDA): 040050
✉ Email this page to a colleague
NDA 040050 describes METHADOSE, which is a drug marketed by Specgx Llc and is included in three NDAs. It is available from two suppliers. Additional details are available on the METHADOSE profile page.
The generic ingredient in METHADOSE is methadone hydrochloride. There are thirteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the methadone hydrochloride profile page.
The generic ingredient in METHADOSE is methadone hydrochloride. There are thirteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the methadone hydrochloride profile page.
Summary for 040050
| Tradename: | METHADOSE |
| Applicant: | Specgx Llc |
| Ingredient: | methadone hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 040050
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Apr 15, 1993 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Apr 15, 1993 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
